Dr. Grover is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
170 Manning Dr
Fl 3
Chapel Hill, NC 27514Phone+1 919-966-1996Fax+1 919-966-6735
Education & Training
University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2014 - 2017
University of Virginia Medical CenterResidency, Internal Medicine, 2011 - 2014
Case Western Reserve University School of MedicineClass of 2011, MD
Certifications & Licensure
NC State Medical License 2014 - 2026
VA State Medical License 2011 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Assessing Physical Fitness in Cancer Patients With Cardiopulmonary Exercise Testing and Wearable Data Generation Start of enrollment: 2016 Feb 01
- Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL Start of enrollment: 2018 Dec 12
- Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma Start of enrollment: 2019 Mar 12
- Join now to see all
Publications & Presentations
PubMed
- Loncastuximab in high-risk and heavily pretreated relapsed / refractory diffuse large B-cell lymphoma: a real-world analysis from 21 US centers.Viktoriya Zelikson, Ashwath Gurumurthi, Yazeed Sawalha, Kaitlin Annunzio, Aditi Saha
Haematologica. 2024-11-14 - 2 citationsCD19-directed CART therapy for T-cell/histiocyte-rich large B-cell lymphoma.Priyanka A Pophali, Joshua A Fein, Kwang W Ahn, Molly Allbee-Johnson, Nausheen Ahmed
Blood Advances. 2024-10-22 - 1 citationsEvaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort study.Natalie S Grover, Kaitlin Annunzio, Marcus Watkins, Pallawi Torka, Reem Karmali
Blood Cancer Journal. 2024-10-18
Abstracts/Posters
- Retrospective Cohort Study Analyzing the Safety and Efficacy of Anti-PD-1 Therapy Following CD30 CAR-T Cell Therapy in Relapsed/Refractory Hodgkin LymphomaNatalie S Grover, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- High Risk Cytogenetic and Immunohistochemistry Findings in Monomorphic Post-Transplant Lymphoproliferative Disorder Following Solid Organ Transplant _ a Single Center ...Natalie S Grover, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Clinical Trial Participation Is Associated with Improved Overall Survival in Newly Diagnosed Patients with Mantle Cell LymphomaNatalie S Grover, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Authored Content
- AstraZeneca's Enhertu Wins Keenly-Anticipated U.S. Breast Cancer NodAugust 2022
- For Crying Out Loud: Dutch Scientists Grow Human Tear GlandsMarch 2021
Press Mentions
What Is the Hippocampus?August 20th, 2021- Strong Response for Tessa’s CD30 CAR-T Cell Therapy in Hodgkin’s Lymphoma TrialSeptember 9th, 2020
- CAR T Cell Therapy Makes Strides in Tackling Hodgkin LymphomaAugust 11th, 2020
- Join now to see all
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
